Cardiovascular disease remains one of the most expensive health conditions in the United States, with direct healthcare costs accounting for approximately 11% of all U.S. healthcare expenditures in 2020–2021, according to the American Heart Association. A single heart attack or major cardiovascular event can have consequences that extend far beyond a patient's health, affecting employers, insurers and healthcare systems through higher medical costs, lost productivity and long-term care expenses. As organizations responsible for employee benefits seek new strategies to identify risk earlier and improve outcomes, Cardio Diagnostics Holdings Inc. (NASDAQ: CDIO) is engaging directly with these stakeholders.
The company announced plans to participate in four national benefits conferences during June, where it will discuss innovative approaches to cardiovascular disease prevention, risk assessment and cost management. Cardio Diagnostics has developed a suite of solutions designed to provide earlier identification of cardiovascular risk and enable more targeted interventions and preventive care. By focusing on benefits professionals, the company aims to address the growing burden of cardiovascular disease on employer-sponsored health plans.
Cardiovascular disease is a leading driver of healthcare spending, and employers are increasingly looking for ways to manage these costs while improving employee health. The conferences provide a platform for Cardio Diagnostics to showcase how its epigenetic-based tests can identify individuals at elevated risk for heart attacks and other cardiovascular events before symptoms appear. Early detection allows for lifestyle modifications and medical interventions that can prevent serious outcomes, potentially reducing claims costs and improving workforce productivity.
The company's participation in these events underscores its commitment to transforming cardiovascular risk assessment from a reactive to a proactive model. Traditional risk factors such as age, cholesterol and blood pressure are insufficient for many individuals, and Cardio Diagnostics' technology offers a more precise and personalized approach. By integrating its tests into employee wellness programs, employers can gain valuable insights into their workforce's cardiovascular health and implement targeted prevention strategies.
For more information on Cardio Diagnostics and its latest news, visit the company's newsroom at https://nnw.fm/CDIO.
NetworkNewsWire (NNW) is a specialized communications platform focused on financial news and content distribution. It is one of 75+ brands within the Dynamic Brand Portfolio @ IBN that delivers access to a vast network of wire solutions, article and editorial syndication to 5,000+ outlets, enhanced press release enhancement, social media distribution via IBN to millions of followers, and a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, NNW is uniquely positioned to serve private and public companies. For more information, visit https://www.NetworkNewsWire.com. Please see full terms of use and disclaimers at https://www.NetworkNewsWire.com/Disclaimer.